BIG PHARMA EARNINGS WATCH: MERCK, GLAXOSMITHKLINE & BRISTOL-MYERS SQUIBB

Brand Name Drug Companies Keep the Good Times Rolling for Shareholders by Price-Gouging American Patients

This week, three more Big Pharma giants proved yet again that hiking prices is a profitable practice for an industry more concerned with pleasing its shareholders than helping patients.  Merck, GlaxoSmithKline (GSK) and Bristol-Myers Squibb all reported sky-high profits this week after engaging in a series of price hikes in 2019.

Over the past year, Merck, GSK and Bristol-Myers Squibb have all hiked prices on American patients.

Merck

GSK
Bristol-Myers Squibb

Merck, GSK and Bristol-Myers Squibb join six other Big Pharma giants who have reported blockbuster earnings after hiking prices on American patients –Johnson & Johnson, Eli Lilly, Roche, Novartis, Pfizer & Amgen. Stay tuned for more as fourth quarter earnings reports continue to roll in.

###

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.